Abstract
1081 BIIB059, a monoclonal antibody targeting BDCA2, decreases Type I Interferon-related genes transcriptional activity in subjects with systemic lupus erythematosus (SLE) and active cutaneous LE (CLE)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have